Bio Protocol (BIO) news: what is happening today

Market summary from our own Hyperliquid data · updated 2026-07-25 04:14 UTC
Bio Protocol falls 11.66% in a month, as our model stays defensive
Bio Protocol is down 11.66% over a month. What follows is what sits behind that move: large-wallet positioning, derivatives, our own model.
What matters on Bio Protocol right now?
Our own rules-based model reads Bio Protocol at 32/100, which is SELL territory. What stands out right now:
- Death cross on the daily chartThe 50-day average crossed below the 200-day; they now sit 4.32% apart.
- Bio Protocol is parked in the lower third of its 90-day range5% of the way up a 90-day range that runs $0.02442 to $0.06602.
- Where the leverage sitsFunding runs at 10.95% a year — longs pay shorts, with $813 K of open interest.
What does the Bio Protocol data show?
1. Death cross on the daily chart
The 50-day moving average crossed below the 200-day. It is a slow signal by construction — both averages look backwards — but it marks the point where the medium-term trend changed sign. Market structure is still making lower highs and lower lows. The most recent daily candle pattern is bullish engulfing. RSI (14) is 42.9.
2. Bio Protocol is parked in the lower third of its 90-day range
Bio Protocol is 5% of the way up its 90-day range, which runs from $0.02442 to $0.06602; over 30 days the market is −11.66%. The same headline number means something different at the top of a range than at the bottom — which is why position is worth naming.
3. Where the leverage sits
Perpetual funding runs at 10.95% annualised, so longs are paying shorts to keep their positions open. Funding is a crowding tax: the more one-sided the book, the more it costs to stay on that side, and the more likely the weakest hands there get squeezed out. Open interest stands at $813 K — that is the size of the leveraged book that has to be closed eventually.
What has already happened to Bio Protocol?
July 2026
- BIO formed a death cross: the 50-day average crossed below the 200-daySMA 50 $0.03221 against SMA 200 $0.03259, 1.18% apart
June 2026
- BIO open interest rose 53.80% to $1.7 M while price moved +5.07%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+5.07%
- BIO open interest rose 58.60% to $2.3 M while price moved +13.28%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+13.28%
- BIO formed a golden cross: the 50-day average crossed above the 200-daySMA 50 $0.03731 against SMA 200 $0.03663, 1.84% apart
Show the earlier history (36 more entries)
May 2026
- BIO open interest rose 69.97% to $4.6 M while price moved +6.36%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+6.36%
- BIO open interest rose 58.12% to $9.8 M while price moved +20.71%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+20.71%
- Bio Protocol closed at a 90-day high of $0.06056Previous peak of the 90-day window $0.05748, exceeded by 5.36%+5.36%
- Bio Protocol closed at a 90-day high of $0.05748Previous peak of the 90-day window $0.04131, exceeded by 39.14%+39.14%
- Bio Protocol moved +42.18% in a day, 3.0× its 30-day volatility30-day standard deviation of daily returns 13.94%+42.18%
April 2026
- Bio Protocol closed at a 90-day high of $0.04131Previous peak of the 90-day window $0.03611, exceeded by 14.39%+14.39%
- BIO open interest rose 74.24% to $5.8 M while price moved +28.69%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+28.69%
- BIO open interest fell 56.28% to $2.6 M while price moved −17.73%: longs unwindingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions−17.73%
- BIO open interest rose 58.72% to $5.9 M while price moved +17.16%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+17.16%
- Bio Protocol moved +56.17% in a day, 15.2× its 30-day volatility30-day standard deviation of daily returns 3.70%+56.17%
March 2026
- Bio Protocol closed at a 180-day low of $0.01617Previous trough of the 180-day window $0.01723, undercut by 6.16%−6.16%
- Bio Protocol closed at a 180-day low of $0.01723Previous trough of the 180-day window $0.01819, undercut by 5.26%−5.26%
- Bio Protocol closed at a 180-day low of $0.01825Previous trough of the 180-day window $0.01921, undercut by 5.03%−5.03%
- Bio Protocol closed at a 180-day low of $0.01921Previous trough of the 180-day window $0.01989, undercut by 3.42%−3.42%
- Bio Protocol closed at a 180-day low of $0.02041Previous trough of the 180-day window $0.02137, undercut by 4.48%−4.48%
February 2026
- Bio Protocol closed at a 180-day low of $0.02137Previous trough of the 180-day window $0.02241, undercut by 4.63%−4.63%
- Bio Protocol moved +40.29% in a day, 6.8× its 30-day volatility30-day standard deviation of daily returns 5.96%+40.29%
- Bio Protocol closed at a 180-day low of $0.02258Previous trough of the 180-day window $0.02358, undercut by 4.25%−4.25%
- Bio Protocol closed at a 180-day low of $0.02457Previous trough of the 180-day window $0.02986, undercut by 17.69%−17.69%
- Bio Protocol moved −17.69% in a day, 3.1× its 30-day volatility30-day standard deviation of daily returns 5.63%−17.69%
- Bio Protocol closed at a 180-day low of $0.03017Previous trough of the 180-day window $0.03226, undercut by 6.48%−6.48%
January 2026
- Bio Protocol closed at a 180-day low of $0.03317Previous trough of the 180-day window $0.03817, undercut by 13.11%−13.11%
- Bio Protocol closed at a 180-day low of $0.03923Previous trough of the 180-day window $0.04055, undercut by 3.25%−3.25%
December 2025
- Bio Protocol closed at a 180-day low of $0.04055Previous trough of the 180-day window $0.04274, undercut by 5.13%−5.13%
- Bio Protocol closed at a 180-day low of $0.04274Previous trough of the 180-day window $0.04421, undercut by 3.33%−3.33%
- Bio Protocol closed at a 90-day low of $0.04421Previous trough of the 90-day window $0.04631, undercut by 4.54%−4.54%
- Bio Protocol closed at a 90-day low of $0.04870Previous trough of the 90-day window $0.05109, undercut by 4.67%−4.67%
- Bio Protocol closed at a 90-day low of $0.05109Previous trough of the 90-day window $0.05564, undercut by 8.18%−8.18%
November 2025
- Bio Protocol closed at a 90-day low of $0.05564Previous trough of the 90-day window $0.05825, undercut by 4.48%−4.48%
- Bio Protocol closed at a 90-day low of $0.05997Previous trough of the 90-day window $0.06348, undercut by 5.53%−5.53%
- Bio Protocol closed at a 90-day low of $0.06743Previous trough of the 90-day window $0.07158, undercut by 5.79%−5.79%
- Bio Protocol closed at a 90-day low of $0.07181Previous trough of the 90-day window $0.07690, undercut by 6.62%−6.62%
October 2025
- BIO open interest rose 141.56% to $3.8 M while price moved +21.34%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+21.34%
- Bio Protocol moved −28.14% in a day, 4.6× its 30-day volatility30-day standard deviation of daily returns 6.07%−28.14%
September 2025
- BIO open interest rose 59.27% to $8.0 M while price moved +1.38%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+1.38%
August 2025
- BIO open interest rose 99.61% to $3.4 M while price moved +34.67%: new longs buildingCompared with a point 1 day(s) earlier; rule: price and open interest moving together means new positions+34.67%
Entries are produced by the Spottrench algorithm from Hyperliquid data.
What is next for Bio Protocol?
Dates we can verify and levels that would change the read on Bio Protocol. No project roadmaps here — only schedules that exist on-chain or in the company calendar, and thresholds measured from our own data.
Unlock schedule from DefiLlama; earnings dates from the company calendar.
The bottom line
Pulling it together, our combined signal reads SELL (32/100, where 50 is neutral). On the last closed day Bio Protocol fell 1.39% against a category median of +0.00%, with 88 of 177 markets in the category closing lower. We do not claim to know why Bio Protocol moved — everything above is measurement, not a cause.
Frequently asked questions
What is the latest news on Bio Protocol?
The most recent development we recorded is: Death cross on the daily chart (2026-07-02). This page is a dated log computed from market data rather than a press feed — every entry is a measurement with the date it happened.
How often is the Bio Protocol page updated?
Once a day: it is recomputed after the daily candle closes, and the time of the last update is printed at the top of the page. Log entries are dated by the day the event happened, not the day we published it.
Where does the Bio Protocol data on this page come from?
From Hyperliquid directly: daily candles, open interest, funding and the on-chain positions of active large wallets. Nothing here is copied from another site's article, and no language model writes the text — the wording is generated from the numbers by fixed rules.
Is this Bio Protocol page investment advice?
No. It is an algorithmic summary of measured market data from Hyperliquid — price moves, positioning, derivatives and our own model. It is not investment advice and past performance does not guarantee future results.
Markets like Bio Protocol
dogwifhat (WIF)SELL
Sky (SKY)NEUTRAL
USD.AI (CHIP)NEUTRAL
Sei (SEI)SELL
Berachain (BERA)SELL
Grass (GRASS)SELL
Other markets on 2026-07-02
Bittensor (TAO)Moving averages
Robinhood (HOOD)New high
Rivian (RIVN)New high
Fartcoin (FARTCOIN)Sharp move
Magic Eden (ME)Sharp move
Sky (SKY)Sharp move
Uniswap (UNI)Sharp move- 📈 EWY (EWY)Volume
ACE
CASHCAT
HEMI
TNSR
ZRO
NOW
HIMS
BE
NBIS
INTC
WLD